Detalhe da pesquisa
1.
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer.
Oncologist
; 27(12): 1004-e926, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124629
2.
Chemical Degradation of Intravenous Chemotherapy Agents and Opioids by a Novel Instrument.
Hosp Pharm
; 56(5): 576-583, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34720163
3.
A rare case of methotrexate and primaquine co-administration in a mantle cell lymphoma patient.
J Clin Pharm Ther
; 44(5): 800-804, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31111511
4.
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.
Haematologica
; 107(10): 2496-2500, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770531
5.
Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer.
J Oncol Pharm Pract
; 22(1): 21-5, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25113309
6.
Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.
J Oncol Pharm Pract
; 22(1): 31-6, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122633
7.
Letter to the Editor Regarding "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement".
Biol Blood Marrow Transplant
; 26(9): e232-e234, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32407883
8.
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer.
Oncologist
; 19(10): 1040-1, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25170013
9.
Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis.
Am J Pathol
; 183(1): 19-25, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23673001
10.
Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia.
Blood
; 119(7): 1658-64, 2012 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22117041
11.
Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions.
J Oncol Pharm Pract
; 20(1): 58-64, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23676513
12.
Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.
J Oncol Pharm Pract
; 20(1): 51-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23512269
13.
Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases.
J Oncol Pharm Pract
; 20(2): 120-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23676510
14.
Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation -a multicentre study.
Lancet Reg Health Am
; 33: 100728, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616918
15.
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
Blood
; 117(8): 2340-7; quiz 2556, 2011 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21148812
16.
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.
Cancer Chemother Pharmacol
; 92(2): 107-118, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314501
17.
Stability of Captisol-enabled versus propylene glycol-based melphalan at room temperature and after refrigeration.
Am J Health Syst Pharm
; 79(12): 1011-1018, 2022 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176751
18.
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.
Cancer Prev Res (Phila)
; 15(12): 791-802, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35981902
19.
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes.
Transplant Cell Ther
; 28(8): 501.e1-501.e7, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618218
20.
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation.
Bone Marrow Transplant
; 57(8): 1295-1303, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35610308